New patent for Novartis drug MAYZENTBy DrugPatentWatch – Make Better Decisions / May 2, 2024 Annual Drug Patent Expirations for MAYZENT Mayzent is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…Source